Abstract

BackgroundMCF-7 breast cancer cell line is undoubtedly amongst the most extensively studied patient-derived research models, providing pivotal results that have over the decades translated to constantly improving patient care. Many research groups, have previously identified suitable reference genes for qPCR normalization in MCF-7 cell line. However, over the course of identification of suitable reference genes, a comparative analysis comprising these genes together in a single study has not been reported. Furthermore, the expression dynamics of these reference genes within sub-clones cultured over multiple passages (p) has attracted limited attention from research groups. Therefore, we investigated the expression dynamics of 12 previously suggested reference genes within two sub-clones (culture A1 and A2) cultured identically over multiple passages. Additionally, the effect of nutrient stress on reference gene expression was examined to postulate an evidence-based recommendation of the least variable reference genes that could be employed in future gene expression studies.ResultsThe analysis revealed the presence of differential reference gene expression within the sub-clones of MCF-7. In culture A1, GAPDH-CCSER2 were identified as the least variable reference genes while for culture A2, GAPDH-RNA28S were identified. However, upon validation using genes of interest, both these pairs were found to be unsuitable control pairs. Normalization of AURKA and KRT19 with triplet pair GAPDH-CCSER2-PCBP1 yielded successful results. The triplet also proved its capability to handle variations arising from nutrient stress.ConclusionsThe variance in expression behavior amongst sub-clones highlights the potential need for exercising caution while selecting reference genes for MCF-7. GAPDH-CCSER2-PCBP1 triplet offers a reliable alternative to otherwise traditionally used internal controls for optimizing intra- and inter-assay gene expression differences. Furthermore, we suggest avoiding the use of ACTB, GAPDH and PGK1 as single internal controls.

Highlights

  • Michigan Cancer Foundation – 7 (MCF-7) breast cancer cell line is undoubtedly amongst the most extensively studied patient-derived research models, providing pivotal results that have over the decades translated to constantly improving patient care

  • The largest variation between Cq values was shown by Heterogenous Nuclear Ribonucleoprotien L (HNRNPL) (S.D = 0.35) in culture A1 and Phosphoglycerate Kinase 1 (PGK1) (S.D = 0.61) in culture A2

  • The present study addresses this issue for the first time and reports evidence of a heterogenous reference gene expression in sub-clones of MCF-7 cell line which are cultured identically

Read more

Summary

Introduction

MCF-7 breast cancer cell line is undoubtedly amongst the most extensively studied patient-derived research models, providing pivotal results that have over the decades translated to constantly improving patient care. Many research groups, have previously identified suitable reference genes for qPCR normalization in MCF-7 cell line. The expression dynamics of these reference genes within sub-clones cultured over multiple passages (p) has attracted limited attention from research groups. We investigated the expression dynamics of 12 previously suggested reference genes within two sub-clones (culture A1 and A2) cultured identically over multiple passages. MCF-7 (Michigan Cancer Foundation 7) is one of the most commonly used patient derived breast cancer cell line. Luminal A subtype tumors were defined as Estrogen Receptor positive (ER+), Progesterone Receptor (PR) ≥ 20%, HER2 negative, Ki67 proliferation marker < 14% and if available, low recurrence risk tumors based on gene-based assays [2]. MCF-7 neoplastic cells were found to be positive for both Estrogen (ER) and Progesterone (PR) receptors along with having low metastatic activity and fulfilled the criteria to be classified as Luminal A molecular subtype tumor cell line [3]

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.